31.12
price down icon3.11%   -1.00
 
loading
Precedente Chiudi:
$32.12
Aprire:
$32.04
Volume 24 ore:
5.68M
Relative Volume:
0.53
Capitalizzazione di mercato:
$12.42B
Reddito:
$5.06B
Utile/perdita netta:
$-2.22B
Rapporto P/E:
-5.3471
EPS:
-5.82
Flusso di cassa netto:
$-3.96B
1 W Prestazione:
-4.72%
1M Prestazione:
+0.10%
6M Prestazione:
-52.67%
1 anno Prestazione:
-70.80%
Intervallo 1D:
Value
$31.02
$32.50
Intervallo di 1 settimana:
Value
$31.02
$34.87
Portata 52W:
Value
$29.25
$170.47

Moderna Inc Stock (MRNA) Company Profile

Name
Nome
Moderna Inc
Name
Telefono
(617) 714-6500
Name
Indirizzo
325 BINNEY STREET, CAMBRIDGE
Name
Dipendente
0
Name
Cinguettio
@moderna_tx
Name
Prossima data di guadagno
2025-02-14
Name
Ultimi documenti SEC
Name
MRNA's Discussions on Twitter

Confronta MRNA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MRNA
Moderna Inc
31.12 12.42B 5.06B -2.22B -3.96B -5.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato Citigroup Neutral
2025-02-18 Downgrade Barclays Overweight → Equal Weight
2025-01-29 Downgrade Goldman Buy → Neutral
2024-12-18 Downgrade Argus Buy → Hold
2024-12-10 Ripresa BofA Securities Underperform
2024-11-19 Iniziato Berenberg Hold
2024-11-18 Aggiornamento HSBC Securities Hold → Buy
2024-11-15 Iniziato Wolfe Research Underperform
2024-10-17 Iniziato Bernstein Mkt Perform
2024-09-13 Downgrade JP Morgan Neutral → Underweight
2024-09-13 Downgrade Jefferies Buy → Hold
2024-09-13 Downgrade Oppenheimer Outperform → Perform
2024-08-28 Aggiornamento HSBC Securities Reduce → Hold
2024-08-07 Aggiornamento Deutsche Bank Sell → Hold
2024-08-05 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Downgrade HSBC Securities Hold → Reduce
2024-01-02 Aggiornamento Oppenheimer Perform → Outperform
2023-11-29 Iniziato Canaccord Genuity Hold
2023-11-03 Aggiornamento HSBC Securities Reduce → Hold
2023-11-02 Downgrade Deutsche Bank Hold → Sell
2023-08-04 Downgrade TD Cowen Outperform → Market Perform
2023-08-03 Downgrade Deutsche Bank Buy → Hold
2023-07-24 Iniziato William Blair Mkt Perform
2023-07-14 Iniziato HSBC Securities Reduce
2023-06-26 Aggiornamento UBS Neutral → Buy
2023-04-26 Iniziato Guggenheim Neutral
2023-03-13 Aggiornamento TD Cowen Market Perform → Outperform
2023-03-02 Iniziato RBC Capital Mkts Outperform
2023-02-24 Downgrade SVB Securities Market Perform → Underperform
2022-12-19 Aggiornamento Jefferies Hold → Buy
2022-12-14 Downgrade Chardan Capital Markets Buy → Neutral
2022-10-21 Aggiornamento SVB Leerink Underperform → Mkt Perform
2022-09-08 Aggiornamento Deutsche Bank Hold → Buy
2022-02-01 Aggiornamento Redburn Sell → Neutral
2022-01-26 Aggiornamento Deutsche Bank Sell → Hold
2022-01-21 Aggiornamento BofA Securities Underperform → Neutral
2022-01-21 Iniziato UBS Neutral
2021-12-07 Iniziato Cowen Market Perform
2021-11-09 Iniziato Wolfe Research Outperform
2021-10-22 Iniziato Deutsche Bank Sell
2021-10-15 Aggiornamento Piper Sandler Neutral → Overweight
2021-08-06 Downgrade Oppenheimer Outperform → Perform
2021-08-06 Downgrade Piper Sandler Overweight → Neutral
2021-07-15 Reiterato Jefferies Hold
2021-02-01 Downgrade BofA Securities Neutral → Underperform
2020-12-16 Downgrade Jefferies Buy → Hold
2020-12-16 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-12-09 Downgrade Needham Buy → Hold
2020-11-23 Iniziato Wells Fargo Equal Weight
2020-11-17 Downgrade BMO Capital Markets Outperform → Market Perform
2020-09-08 Downgrade SVB Leerink Mkt Perform → Underperform
2020-07-23 Iniziato SVB Leerink Mkt Perform
2020-07-20 Downgrade JP Morgan Overweight → Neutral
2020-07-13 Iniziato Jefferies Buy
2020-06-30 Iniziato Argus Buy
2020-06-08 Iniziato Barclays Overweight
2020-04-30 Iniziato BMO Capital Markets Outperform
2020-03-05 Downgrade BofA/Merrill Buy → Neutral
2019-12-03 Ripresa BofA/Merrill Buy
2019-10-25 Iniziato ROTH Capital Buy
2019-04-05 Iniziato Chardan Capital Markets Buy
Mostra tutto

Moderna Inc Borsa (MRNA) Ultime notizie

pulisher
06:21 AM

Teacher Retirement System of Texas Purchases 12,651 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

06:21 AM
pulisher
05:06 AM

Mitsubishi UFJ Trust & Banking Corp Has $25.79 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

05:06 AM
pulisher
Mar 28, 2025

KLP Kapitalforvaltning AS Invests $4.44 Million in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

Vanguard Group Inc. Boosts Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

Moderna, Inc. (NASDAQ:MRNA) Stake Lowered by Corient Private Wealth LLC - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

Royal London Asset Management Ltd. Sells 178,991 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

Is Moderna Stock A Sell With RFK Jr. Reportedly Eyeing Funds? - Investor's Business Daily

Mar 27, 2025
pulisher
Mar 27, 2025

Jim Cramer: Moderna (MRNA) Blew It – But Their Cash Pile Could Save Them! - Insider Monkey

Mar 27, 2025
pulisher
Mar 27, 2025

Moderna's Options Frenzy: What You Need to Know - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

Moderna, Inc. (MRNA): Among Stocks To Trade Without Tariffs And Interest Rate Fears - Insider Monkey

Mar 27, 2025
pulisher
Mar 27, 2025

Motley Fool Wealth Management LLC Sells 31,583 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

Trump administration at ‘war’ with mRNA technology: scientists alarmed vaccine skeptics could kill research - Inkl

Mar 27, 2025
pulisher
Mar 26, 2025

As Vaccine Skepticism Mounts, Moderna’s Business Grows More Precarious - Barron's

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna chief brand officer Kate Cronin exits pharma giant - MM+M Online

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?Moderna (NASDAQ:MRNA) - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Inc. (NASDAQ:MRNA) Given Average Rating of "Hold" by Analysts - MarketBeat

Mar 26, 2025
pulisher
Mar 26, 2025

JPMorgan Chase & Co. Lowers Moderna (NASDAQ:MRNA) Price Target to $33.00 - MarketBeat

Mar 26, 2025
pulisher
Mar 26, 2025

Northwest & Ethical Investments L.P. Grows Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 26, 2025
pulisher
Mar 25, 2025

Is Moderna, Inc. (MRNA) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025
pulisher
Mar 25, 2025

Raymond James Financial Inc. Purchases New Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars? - Crowell & Moring LLP

Mar 24, 2025
pulisher
Mar 24, 2025

Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025 - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks - Yahoo Finance

Mar 24, 2025
pulisher
Mar 24, 2025

Avantax Advisory Services Inc. Invests $483,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 24, 2025
pulisher
Mar 24, 2025

Privium Fund Management B.V. Increases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

mRNA Patent Wars Update: The Plot Thickens with Key Rulings Expected in 2025 - IPWatchdog.com

Mar 23, 2025
pulisher
Mar 22, 2025

Moderna price target lowered to $33 from $40 at JPMorgan - Yahoo Finance

Mar 22, 2025
pulisher
Mar 22, 2025

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move - The Motley Fool

Mar 22, 2025
pulisher
Mar 21, 2025

Wealthfront Advisers LLC Lowers Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

JPMorgan Cuts Price Target on Moderna to $33 From $40, Maintains Underweight Rating - Marketscreener.com

Mar 21, 2025
pulisher
Mar 21, 2025

Proficio Capital Partners LLC Raises Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 21, 2025
pulisher
Mar 20, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Swiss National Bank - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

Skandinaviska Enskilda Banken AB publ Decreases Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

U.S. to spend $100M to develop bird flu vaccines, drugs (MRNA) (MRNA:NASDAQ) - Seeking Alpha

Mar 20, 2025
pulisher
Mar 20, 2025

Moderna's Options: A Look at What the Big Money is Thinking - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

4 Things You Need to Know if You Buy Moderna Stock Today - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Intact Investment Management Inc. Invests $420,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 20, 2025
pulisher
Mar 19, 2025

Victory Capital Management Inc. Sells 168,512 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 19, 2025
pulisher
Mar 19, 2025

Moderna. Why Anti-Covid19 Juggernaut Goes 'The Bloodmachine' for NASDAQ:MRNA by PandorraResearch - TradingView

Mar 19, 2025

Moderna Inc Azioni (MRNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Moderna Inc Azioni (MRNA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
SAGAN PAUL
Director
Mar 03 '25
Buy
31.76
31,620
1,004,251
312,027
Klinger Shannon Thyme
Chief Legal Officer
Dec 09 '24
Sale
44.68
529
23,637
20,446
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
Capitalizzazione:     |  Volume (24 ore):